期刊
CLEVELAND CLINIC JOURNAL OF MEDICINE
卷 77, 期 4, 页码 236-242出版社
CLEVELAND CLINIC
DOI: 10.3949/ccjm.77a.09147
关键词
-
资金
- GlaxoSmithKline
- MAP
- Merck
When patients who have frequent, disabling migraines take medications to relieve their symptoms, they run the risk that the attacks will increase in frequency to daily or near-daily as a rebound effect comes into play. This pattern, called medication overuse headache, is more likely to happen with butalbital and opioids than with migraine-specific drugs, as partial responses lead to recurrence, repeat dosing, and, eventually, overuse. Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据